Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2012

View Archived Issues

Virus-mediated neuroprotection demonstrated in model of Parkinson's disease

New protein kinase modulators designed by Ambit Biosciences

Lexicon Pharmaceuticals provides first description of early development of LX-4211

Researchers at Vertex Pharmaceuticals identify new selective PLK1 inhibitor

Gruenenthal team prepares novel voltage-gated potassium channel modulators

Merck & Co. synthesizes novel ERK inhibitors

Scientists at Merck KGaA patent new protein kinase inhibitors

Anacetrapib improves dyslipidemia in Japanese trial

Antisense therapy shows promise in phase I study

New details disclosed on phase I cenderitide trial

Abide Therapeutics and Scynexis announce collaboration

Phase I trials of e-Therapeutics anticancer drug clear to proceed

FDA clarifies dose and warning recommendations for antidepressant

SymBio's notification for phase I rigosertib study accepted in Japan

Kiklin capsules approved in Japan

U.S. university researchers prepare novel c-Met inhibitors

GSK and DSP set to copromote antidepressant in Japan

Apokyn approved for marketing in Japan

New mTOR inhibitors presented by Merck & Co.

Zeria files for approval of oral phosphate hypophosphatemia drug in Japan

Chugai obtains approval in Japan for cystic fibrosis treatment

Toray and Taiho discontinue codevelopment of beta3-adrenoceptor agonist

Pfizer and Astellas amend Lipitor licensing agreement

New product approved for T-cell leukemia-lymphoma

GenSpera advances phase I study of lead chemotherapeutic agent

Optimer and Astellas enter commercialization agreement for fidaxomicin tablets

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...